Form 8-K - Current report:
SEC Accession No. 0001437749-25-013630
Filing Date
2025-04-30
Accepted
2025-04-30 07:29:39
Documents
17
Period of Report
2025-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250429_8k.htm   iXBRL 8-K 60642
2 EXHIBIT 10.1 ex_809190.htm EX-10.1 330695
3 EXHIBIT 10.2 ex_809191.htm EX-10.2 195020
4 EXHIBIT 99.1 ex_809189.htm EX-99.1 353298
  Complete submission text file 0001437749-25-013630.txt   1287482

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20250429.xsd EX-101.SCH 3580
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250429_def.xml EX-101.DEF 11808
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250429_lab.xml EX-101.LAB 15859
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250429_pre.xml EX-101.PRE 12023
19 EXTRACTED XBRL INSTANCE DOCUMENT wint20250429_8k_htm.xml XML 2949
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25890991
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)